• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.78% Nasdaq Down 1.13%

    Cytori Therapeutics, Inc. (CYTX)

    -NasdaqCM
    0.27 Down 0.03(9.80%) 3:59PM EDT
    Prev Close:0.30
    Open:0.31
    Bid:0.28 x 100
    Ask:0.30 x 900
    1y Target Est:2.33
    Beta:3.24954
    Next Earnings Date:10-May-16CYTX Earnings announcement
    Day's Range:0.27 - 0.31
    52wk Range:0.13 - 0.85
    Volume:3,037,096
    Avg Vol (3m):1,891,630
    Market Cap:53.49M
    P/E (ttm):N/A
    EPS (ttm):-0.19
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    CYTXDown 9.80%53.49M
    BAXDown 0.72%24.42B
    OSIRDown 7.30%183.63M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):3.94
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :-0.12
    Quarterly EPS Est (Mar-16) :-0.03
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Cytori Therapeutics, Inc., a biotechnology company, develops cellular therapeutics for specific diseases and medical conditions. The company primarily provides Cytori Cell Therapy consisting of a heterogeneous population of specialized cells, incl... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback